DAB2IP and gastric cancer: On the basis of IHC staining scoring, the DAB2IP was positively expressed in 39.0% (23/59) of GC samples; in contrast, 69.5% (41/59) of the matched tumour‐adjacent tissues exhibited DAB2IP‐positive expression (P = 0.01).